Atlas responds to recommendation of the Independent Committee of the Board of Directors of Millicom International Cellular S.A.
Atlas Investissement
Atlas Investissement

Luxembourg, July 17, 2024 (GLOBE NEWSWIRE) -- This announcement is not an offer, whether directly or indirectly, in Australia, Belarus, Canada, Hong Kong, Japan, New Zealand, Singapore, South Africa or Russia or in any other jurisdiction where such offer would be prohibited by applicable law pursuant to legislation, restrictions and regulations in the relevant jurisdiction. Shareholders not resident in Sweden or the United States who wish to accept the Offers (as defined below) must make inquiries concerning applicable legislation and possible tax consequences. Shareholders should refer to the offer restrictions included in the section titled “Important notice” at the end of this announcement and in the Offer to Purchase, which was published on July 1, 2024. United States shareholders should refer to the section titled “Important Information” and “Special Notice to Shareholders in the United States” at the end of this announcement.


Atlas responds to recommendation of the Independent Committee of the Board of Directors of Millicom International Cellular S.A.

Atlas Luxco S.à r.l.1 (“Atlas” or the “Purchaser”), a subsidiary of Atlas Investissement S.A.S.1, acknowledges the negative recommendation of the Independent Committee of the Board of Directors of Millicom International Cellular S.A. (“Millicom” or the “Company”) issued on July 15, 2024, which was expected given its prior communication on June 27, 2024. Atlas does not believe that the negative recommendation contains any new meaningful argument compared to such prior communication. Atlas’ offer price remains USD 24.00 per common share and USD 24.00 per Swedish Depository Receipt (each, an “SDR” and collectively, the “SDRs,” and together with the common shares, the “Shares”) which deliver compelling value and a unique liquidity opportunity to the Company’s Shareholders. Holders of common shares and SDRs will collectively be referred to herein as “Shareholders.”

Compelling value:

  • We believe that the premium should not be measured against prices after May 22, 2024, when rumors about the separate but concurrent public offers in Sweden and the United States, (the “Offers”) became public, and it is not market practice to do so. We note that equity research analysts speculated about Atlas’ potential interest even before May 22, 2024. The price of the Offers of USD 24.00 per common share and USD 24.00 per SDR (the “Offer Price”) represents an 18.8% premium compared to the volume weighted average trading price for the Shares during the last 90 calendar days ended on May 22, 20242, a 27.1% per cent premium compared to the volume weighted average trading price for the Shares during the last 180 calendar days ended on May 22, 20243 and a 37.8% premium compared to the volume weighted average trading price for the Shares during the last 365 calendar days ended on May 22, 20244.5

  • Atlas communicated a detailed valuation assessment of Millicom as part of its Offers, reflecting the most commonly used methodologies for Offers of this type (including a historical trading analysis, a brokers’ target price analysis, a discounted cash flow analysis and a comparable trading and transactions multiples analysis), while the Independent Committee’s press release only references two very specific and uncommon trading multiples.

  • Atlas advises Shareholders to exercise caution when considering the relevance of new and uncertain projections prepared by the Independent Committee solely in the context of responding to the Offers.